• NEWS

COVID antibody drugs work best when given as early as possible

Data from dozens of trials also suggest that antibody treatments could be given in much smaller amounts than current practice.
By
  1. Ewen Callaway
    View author publications

    You can also search for this author in PubMed  Google Scholar

Access through your institution
Buy or subscribe

A first-of-its-kind analysis has a clear message about when to give the COVID-19 therapies called monoclonal antibodies: the earlier people get this type of treatment, the better they fare1.

Access options

Access through your institution

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-022-00893-y

References

  1. Stadler, E. et al. Preprint at medRxiv https://doi.org/10.1101/2022.03.21.22272672 (2022).

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing